Editorial overview: New technologies: drug delivery and medical devices combinations, more than the sum of the parts
Files in This Item:
|Editorial_overview_Brayden_&_Hirst_FINAL.docx||23.3 kB||Microsoft Word||Download Request a copy|
|Title:||Editorial overview: New technologies: drug delivery and medical devices combinations, more than the sum of the parts||Authors:||Brayden, David James
Hirst, Barry H.
|Permanent link:||http://hdl.handle.net/10197/9308||Date:||Oct-2017||Abstract:||In this New Technologies Issue of Current Opinion in Pharmacology, we were tasked with finding a set of articles of interest to readers on the topic of combination technologies involving drug delivery and medical devices, with an emphasis on pharmacological aspects. Most of the authors are experts in biomaterials and understand how they can be used in devices. Yet, they all pay attention to pharmacology since the technologies they are developing are designed to fulfil an unmet therapeutic need in terms of localising a molecule to a region in the body, thereby reducing toxicity and improving PK/pharmacodynamics (PD), or of causing an optimised controlled release profile of a molecule in the systemic circulation to improve efficacy, reduce side effects, or to address compliance issues.||Funding Details:||Science Foundation Ireland||Type of material:||Journal Article||Publisher:||Elsevier||Copyright (published version):||2017 Elsevier||Keywords:||Drug-device combinations;Medical devices||DOI:||10.1016/j.coph.2017.11.007||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Veterinary Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.